About KBP BioSciences
KBP BioSciences is a company based in Princeton (United States) founded in 2007.. KBP BioSciences has raised $76 million across 1 funding round from investors including SDIC, Efung Capital and Advantech Capital. KBP BioSciences operates in a competitive market with competitors including AskBio, Calliditas Therapeutics, Juvenescence, Insmed and Inotrem, among others.
- Headquarter Princeton, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$76 M (USD)
in 1 rounds
-
Latest Funding Round
$76 M (USD), Series A
Jan 05, 2018
-
Investors
SDIC
& 9 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of KBP BioSciences
KBP BioSciences has successfully raised a total of $76M through 1 strategic funding round. The most recent funding activity was a Series A round of $76 million completed in January 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $76.0M
-
First Round
First Round
(05 Jan 2018)
- Investors Count 10
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2018 | Amount | Series A - KBP BioSciences | Valuation | Advantech Capital , SDIC |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in KBP BioSciences
KBP BioSciences has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include SDIC, Efung Capital and Advantech Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Efung Capital is focused on global biopharmaceutical investments.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
A venture capital firm focused on life sciences investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by KBP BioSciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - KBP BioSciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Kbp Biosciences Comparisons
Competitors of KBP BioSciences
KBP BioSciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as AskBio, Calliditas Therapeutics, Juvenescence, Insmed and Inotrem, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Gene and protein therapies are developed for treating various diseases.
|
|
| domain | founded_year | HQ Location |
Provider of small molecule based drug for inflammatory kidney disease
|
|
| domain | founded_year | HQ Location |
Provider of proprietary ketone ester-based therapeutic drink for age-related disorders and metabolic health
|
|
| domain | founded_year | HQ Location |
Developer of small molecule inhibitors for rare lung diseases
|
|
| domain | founded_year | HQ Location |
Developer of peptide immunotherapies for treating septic shock and acute myocardial infarction
|
|
| domain | founded_year | HQ Location |
Technology-based conjugate vaccines against infectious diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Kbp Biosciences
Frequently Asked Questions about KBP BioSciences
When was KBP BioSciences founded?
KBP BioSciences was founded in 2007 and raised its 1st funding round 11 years after it was founded.
Where is KBP BioSciences located?
KBP BioSciences is headquartered in Princeton, United States. It is registered at Princeton, New Jersey, United States.
Is KBP BioSciences a funded company?
KBP BioSciences is a funded company, having raised a total of $76M across 1 funding round to date. The company's 1st funding round was a Series A of $76M, raised on Jan 05, 2018.
What does KBP BioSciences do?
KBP Biosciences is developing medicine with a focus on following therapeutic areas: inflammatory and autoimmune diseases, major organ degeneration, and drug-resistant bacterial infection, as well as cancers and gastrointestinal disorders. Its drug pipeline inlcudes KBP-5074 (MR-specific antogonist) Chronic Kidney DiseaseHeart Failure (Phase 2); KBP-7072, a next generation tetracycline for multi-resistant bacterial infection (Phase 1). The company also have drug sin development for Asthma COPD; Fibrosis; Rheumatoid arthritis and Gram-Negative bacteria infections.
Who are the top competitors of KBP BioSciences?
KBP BioSciences's top competitors include Juvenescence, AskBio and Calliditas Therapeutics.
Who are KBP BioSciences's investors?
KBP BioSciences has 10 investors. Key investors include SDIC, Efung Capital, Advantech Capital, Sangel Capital, and Ping An Ventures.